Educational Seminar (ES-1) AstraZeneca K.K.
Language: Japanese Slide: Japanese

Live streaming 12:45 - 14:00, Thursday, September 17

Title “The Forefront of Asthma Treatment Evolution -Mild to Severe Asthma-”

Chair 

Kazuto Matsunaga (Yamaguchi University Hospital, Yamaguchi, Japan)

Speakers 

“Current Topics of Asthma Management and Appropriate Approach to Prevent Viral-infection-induced Exacerbation”

Masayuki Hojo (Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan)

“Targeted biologics shift the paradigm in severe asthma treatment”

Norihiro Harada (Juntendo University Hospital, Tokyo, Japan)

Educational Seminar (ES-2) Mylan EPD G.K.
Language: Japanese/English Slide: Japanese/English

On-demand platform

“Anaphylaxis in Practice with Clinical Cases -Up-to-date Information About Diagnosis, Treatment and Patient Education of Anaphylaxis-”

Chair 

Motohiro Ebisawa (Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Kanagawa, Japan)

Speakers 

“Diagnosis of Anaphylaxis based on Guidelines”

Antonella Muraro (Padua University Hospital, Padua, Italy)

“Importance of Continuing Treatment of Patient with a History of Anaphylaxis”

Margitta Worm (Charité - Universitätsmedizin Berlin, Berlin, Germany)

“The Latest Patient Education to be Properly Ready for Anaphylaxis”

Sakura Sato (Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Kanagawa, Japan)

Educational Seminar (ES-3) GlaxoSmithKline K.K.
Language: Japanese Slide: Japanese

Live streaming 12:45 - 14:00, Thursday, September 17

“Implementing the management for severe asthma in practice”

Chair 

Nobuyuki Hizawa (University of Tsukuba, Ibaraki, Japan)

Speaker 

Satoshi Marumo (Kitano Hospital, Osaka, Japan)

Educational Seminar (ES-4) Novartis Pharma K.K.
Language: Japanese(with interpreter) Slide: English

Live streaming 12:45 - 14:00, Thursday, September 17

“What should U-CARE be like, encompassing everything from diagnosis to treatment follow-up? ”

Chair 

Michihiro Hide (Hiroshima University, Hiroshima, Japan)

Speakers 

“Current status and future issues of the UCARE Center in Japan -Diagnosis, treatment and medical cooperation for urticaria patients-”

Atsushi Fukunaga (Kobe University Graduate School of Medicine, Kobe, Japan)

“The Global UCARE Network: Aims, Structure, Projects and Perspectives”

Marcus Maurer (Charité - Universitätsmedizin Berlin, Berlin, Germany)

Educational Seminar (ES-5) Sanofi K.K.
Language: Japanese Slide: English

Live streaming 12:45 - 14:00, Thursday, September 17

“Type 2 inflammation in Upper and Lower Airway”

Chair 

Akihito Yokoyama (Kochi University, Kochi, Japan)

Speakers 

“Chronic rhinosinusitis with nasal polyps: pathogenesis and new treatment approach”

Yuji Nakamaru (Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan)

“Pathophysiology and optimal treatment of adult severe asthma”

Masami Taniguchi (Shonan Kamakura General Hospital, Kanagawa, Japan)

Educational Seminar (ES-6) SYSMEX CORPORATION
Language: English Slide: English

On-demand platform

“Advanced atopic dermatitis treatment by serum biomarker “TARC” guided precise medicine

Chair 

Masutaka Furue (Kyushu University, Fukuoka, Japan)

Speakers 

Yoko Kataoka (Osaka Habikino Medical Center, Osaka, Japan)

Educational Seminar (ES-7) Sanofi K.K.
Language: Japanese(with interpreter) Slide: English

Live streaming 12:45 - 14:00, Thursday, September 17

“Refractory Chronic Rhinosinusitis ‘UP TO DATE’”

Chair 

Shigeharu Fujieda (University of Fukui, Fukui, Japan)

Speakers 

“Type 2 inflammation and its burden on chronic rhinosinusitis and nasal polyps”

Mitsuhiro Okano (International University of Health and Welfare (IUHW), School of Medicine, Tochigi, Japan)

“Steroid resistant rhinosinusitis　-Closs Talk with Basic and Clinics-“

Nobuo Ohta (Tohoku Medical and Pharmaceutical University, Miyagi, Japan)

Educational Seminar (ES-8) Novartis Pharma K.K.
Language: Japanese(with interpreter) Slide: English

Live streaming 12:15 -13:30, Friday, September 18

“How will treatment for moderate to severe asthma change?”

Chair 

Hiromasa Inoue (Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan)

Speakers 

“Current situation and issues of management for moderate to severe asthma”

Kazuto Matsunaga (Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan)

“New options for treatment of moderate to severe asthma”

Yasuhiro Gon (Nihon University, Tokyo, Japan)

Educational Seminar (ES-9) GlaxoSmithKline K.K.
Language: Japanese Slide: Japanese

Live streaming 12:15 -13:30, Friday, September 18

“COPD”

Chair 

Ichiro Kuwahira (Tokai University Tokyo Hospital, Tokyo, Japan)

Speakers 

“The Role of Triple Therapy in COPD Treatment”

Hisatoshi Sugiura (Tohoku University Graduate School of Medicine, Miyagi, Japan)

“IMPACT of Triple Therapy”

Soichiro Hozawa (Hiroshima Allergy & Respiratory Clinic Hacchobori, Hiroshima, Japan)

Educational Seminar (ES-10) Thermo Fisher Scientific
Language: Language: Japanese Slide: Japanese

On-demand platform

“Clinical significance of fungal specific IgE testing in severe asthma and allergic bronchopulmonary aspergillosis (ABPA).”

Chair 

Koichiro Asano (Tokai University School of Medicine, Kanagawa, Japan)

Speakers 

“Opening Remarks”

Koichiro Asano (Tokai University School of Medicine, Kanagawa, Japan)

“The importance of fungal specific IgE testing in allergic bronchopulmonary aspergillosis (ABPA).”

Yuma Fukutomi (Clinical Research Center for Allergology and Rheumatology, National Hospital Organaization Sagamihara National Hospital, Kanagawa, Japan)

“Clinical implications of fungal sensitization in severe asthma”

Masami Taniguchi (Shonan Kamakura General Hospital, Kanagawa, Japan)

Educational Seminar (ES-11) Sanofi K.K.
Language: Japanese(with interpreter) Slide: English

Live streaming 12:15 -13:30, Friday, September 18

“Skin barrier destruction in Atopic Dermatitis”

Chair 

Kenji Kabashima (Kyoto University Graduate School of Medicine, Kyoto, Japan)

Speakers 

“Therapeutic strategies of atopic dermatitis”

Saeko Nakajima (Kyoto University Graduate School of Medicine, Kyoto, Japan)

Yoshiki Tokura (Hamamatsu University School of Medicine, Shizuoka, Japan)

Educational Seminar (ES-12) Torii Pharmaceutical Co.,Ltd.
Language: Japanese Slide: Japanese/English

Live streaming 19:00 -20:15, Friday, September 18

“Sublingual immunotherapy”

Chair 

Sankei Nishima (National Hospital Organization Fukuoka Hospital, Fukuoka, Japan)

Speakers 

“Sublingual immunotherapy for allergic rhinitis in Japan”

Kimihiro Okubo (Nippon Medical School, Tokyo, Japan)

“Allergen immunotherapy in children”

Takao Fujisawa (Mie National Hospital, Mie, Japan)

Educational Seminar (ES-13) Sanofi K.K.
Language: English(with interpreter) Slide: English

Live streaming 12:15 -13:30, Saturday, September 19

“Treatment strategy of focus on IL-4/13 in severe asthma”

Chair 

Takeshi Kaneko (Yokohama City University Graduate School of Medicine, Kanagawa, Japan)

Speakers 

“Role of IL-4/13 in the pathogenesis of severe asthma”

Koichiro Matsumoto (Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)

“Update on clinical evidences for biologics in moderate to severe asthma”

Mario Castro (Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine)

Educational Seminar (ES-14) Novartis Pharma K.K.
Language: Japanese(with interpreter) Slide: Japanese/English

Live streaming 12:15 -13:30, Saturday, September 19

“The selection of a biologic in severe asthma”

Chair 

Makoto Nagata (Saitama Medical University, Saitama, Japan)

Speakers 

“New development of cedar pollinosis treatment with anti-IgE antibody”

Minoru Gotoh (Nippon Medical School, Tokyo, Japan)

“Molecular targeted therapy for severe asthma -Comorbidity and treatment choice-”

Hiroyuki Nagase (Teikyo University School of Medicine, Tokyo, Japan)

Educational Seminar (ES-15) Maruho Co., Ltd.
Language: Japanese(with interpreter) Slide: English

Live streaming 16:30 -17:45, Saturday, September 19

“Mechanism and Treatment of Itch in Atopic dermatitis”

Chair 

Norito Katoh (Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan)

Keynote Lecture (15 min：16:30～16:45)

Speakers 

“Clinical aspect of pruritus in atopic dermatitis”

Norito Katoh (Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan)

Lecture (50 min：16:45～17:35)

Speakers 

“The molecular and cellular bases of itch in atopic dermatitis”

Mitsutoshi Tominaga (Juntendo University Graduate School of Medicine Institute for Environmental and Gender Specific Medicine / Juntendo Itch Research Center, Japan)

Q&A (10 min：17:35～17:45)

Educational Seminar (ES-16)
SHIONOGI & CO., LTD. / STALLERGENES GREER
Language: English Slide: English

Live streaming 12:15 -13:30, Saturday, September 19

“Shaping the horizons of patients living with HDM allergic rhinitis”

Chair 

Yoshitaka Okamoto (Chiba Rousai Hospital, Chiba, Japan)

Ruby Pawankar (Nippon Medical School, Tokyo, Japan)

Speaker 

“What benefit can HDM SLIT-tablet provide to patients living with HDM allergic rhinitis?”

Mitsuhiro Okano (International University of Health and Welfare Graduate School of Medicine, Tochigi, Japan)

“Personalized medicine for allergy treatment: AIT still a unique and unmatched model”

Giorgio Walter Canonica (Humanitas University and Research, Hospital ICH, Milan, Italy)

Educational Seminar (ES-17) AstraZeneca K.K.
Language: Japanese Slide: Japanese

Live streaming 12:15 -13:30, Saturday, September 19

“Update COPD treatment”

Chair 

Takahide Nagase (The University of Tokyo Hospital, Tokyo, Japan)

Speakers 

“Practice of diagnosis and treatment of Asthma-COPD overlap”

Yoko Shibata (Fukushima Medical University Hospital, Fukushima, Japan)

“Inhaler medicine choice based on evidence”

Koichiro Takahashi (Saga University Hospital, Saga, Japan)

Educational Seminar (ES-18) GlaxoSmithKline K.K.
Language: Japanese Slide: Japanese

Live streaming 12:15 -13:30, Saturday, September 19

“Asthma”

Chair 

Koichi Fukunaga (Keio University School of Medicine, Tokyo, Japan)

Speakers 

“Anti-inflammatory therapy and its monitoring in asthma”

Junpei Saito (Fukushima Medical University Hospital, Fukushima, Japan)

“Efficacy and safety of ICS : From the viewpoint of therapeutic index”

Jun Tamaoki (GlaxoSmithKline K.K., Japan)

Educational Seminar (ES-19) Sanofi K.K.
Language: Japanese(with interpreter) Slide: English

Live streaming 12:15 -13:15, Sunday, September 20

“Type2 inflammation in Allergic disease”

Chair 

Motohiro Ebisawa (Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Kanagawa, Japan)

Speakers 

“Pathophysiology and treatment of chronic rhinosinusitis ― up-to-date”

Kenji Kondo (Graduate School of Medicine, The University of Tokyo, Tokyo, Japan)

“Role of IL-4/13 in the pathophysiology of asthma”

Toshiyuki Koya (Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan)

“Pathogenesis of atopic dermatitis in the context of cytokines :Long term clinical experience of Dupixent in the treatment of atopic dermatitis”

Yozo Ishiuji (Jikei University Tokyo, Tokyo, Japan)

Educational Seminar (ES-20) Mylan EPD G.K.
Language: Japanese Slide: Japanese

On-demand platform

“Future Outlook of Food Allergy and Anaphylaxis Management”

Chair 

Yukihiro Ohya (National Center for Child Health and Development, Tokyo, Japan)

Speaker 

Takanori Imai (Showa University Hospital, Tokyo, Japan)

Educational Seminar (ES-21) Thermo Fisher Scientific
Language: Japanese Slide: Japanese

On-demand platform

“Component-resolved diagnostics in food allergy practice”

Chair 

Yusei Ohshima (Faculty of Medical Sciences, University of Fukui, Fukui, Japan)

Speakers 

“Limitations of specific IgE antibody test and component-resolved diagnostics”

Mizuho Nagao (National Hospital Organization Mie National Hospital, Mie, Japan)

“Approach to special type food allergy diagnosis”

Naoko Inomata (Yokohama City University Graduate School of Medicine, Kanagawa, Japan)

Educational Seminar (ES-22) KYORIN Pharmaceutical Co. Ltd.
Language: Japanese Slide: Japanese

Live streaming 12:15 -13:15, Sunday, September 20

“Reconsider inhalation therapy in asthma ~ the benefits of using aerosol device~”

Chair 

Yuji Tohda (KINDAI University Hospital, Osaka, Japan)

Speakers 

“Reconsider the benefits of inhaled corticosteroid treatment using a metered dose inhaler”

Hisako Matsumoto (Graduate School of Medicine, Kyoto University, Kyoto, Japan)

“What are more beneficial inhalation medications and devices for patients with asthma”

Hiroyuki Ohbayashi (Tohno-Chuo Clinic, Gifu, Japan)

Educational Seminar (ES-23)
Santen Pharmaceutical Co., Ltd./Mitsubishi Tanabe Pharma Corporation
Language: Japanese Slide: English

Live streaming 12:15 -13:15, Sunday, September 20

“Current status and issues of allergic conjunctival disease in Japan：epidemiology , pathophysiology , medical examination”

Chair 

Nobuyuki Ebihara (Juntendo University Urayasu Hospital, Chiba, Japan)

Speakers 

“Classification and epidemiology of allergic conjunctival diseases in Japan”

Dai Miyazaki (Tottori University, Tottori, Japan)

“Characteristics of allergic conjunctival diseases in Japan”

Jun Shoji (Nihon University School of Medicine, Tokyo, Japan)

“Medical treatment of allergic conjunctival disease”

Atsuki Fukushima (Kochi Medical School, Kochi, Japan)

“Effects of the compliance of anti‐histamine ophthalmic solutions on Quality of Life in patients with seasonal allergic conjunctivitis using web questionnaire”

Kazumi Fukagawa (Ryogoku Eye Clinic, Tokyo, Japan)

Educational Seminar (ES-24) Hisamitsu Pharmaceutical Co.,Inc.
Language: Japanese Slide: Japanese

Live streaming 12:15 -13:15, Sunday, September 20

“Pitfall of diagnosis & treatment for Allergic Rhinitis, CRS. - What is Plan B?”

Chair 

Daiju Sakurai (School of Medicine, University of Yamanashi, Yamanashi, Japan)

Speaker 

Mikiya Asako (Kansai Medical University Medical Center, Osaka, Japan)